Wave Life Sciences sets Aug. 7 completion for Delaware redomiciliation
Reuters2026/08/05 20:52- Wave Life Sciences set Aug. 7, 2026 as the expected completion date for its redomiciliation to the US.
- The corporate reorganization shifts the group’s parent company from Singapore to a Delaware corporation.
- The Singapore High Court approved the scheme of arrangement on July 14, 2026.
- The move is expected to take effect after the close of trading on Aug. 7, 2026.
- Wave plans to file a series of SEC forms after market close on the effective date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs: AI storage chip demand is underestimated, South Korean stock market still has 80% upside potential
Goldman Sachs Asia-Pacific Chief Equity Strategist Timothy Moe maintains a KOSPI target of 12,000 points, implying an almost 80% increase from the current level. He points out that the market is systematically underestimating the sustainability of the AI storage chip profit cycle. Capital expenditures by US tech giants may exceed $1.2 trillion next year, and the chip shortage triggered by data center expansion will further intensify in 2027. The current KOSPI is trading at only 5.3 times expected earnings, about half of its historical average.
Norwegian sovereign wealth fund may cut $80 billion US Treasury holdings; high-rated mortgage securities expected to become new favorites
Norway's sovereign wealth fund, with a scale of $2.3 trillions, has recommended reducing government bond holdings and reallocating funds towards higher-yielding fixed income assets.
Barclays names Takeo Kamai head of high-touch sales trading, Japan
Crypto prices
More
